De-Risking Cell Culture Media Scale-Up for Late-Stage Manufacturing

Strategies for supply assurance, QC readiness, digital optimization, and commercial bioprocessing success.

The translation of cell culture processes from laboratory-scale development to commercial manufacturing remains one of the most critical challenges in bioprocessing. While small-scale systems provide valuable insights into cell growth, productivity, and product quality, scale-up introduces complex engineering and biological variables that can significantly impact process performance. Scale-up also comes with additional considerations that can greatly impact efficiency, cost and speed-to-market.

In this webinar, a panel of experienced professionals from Thermo Fisher Scientific will explore potential challenges encountered during cell culture media manufacturing scale-up, options and solutions. A sample of topics will include:

Supply assurance—approaches to help ensure transparent and uninterrupted global supply of your cell culture media
Benefits of granular cell culture media formats, including preparation time productivity and financial savings models
Managing emerging QC considerations to meet new regulatory requirements
How digital tools are helping change how media formulations are designed and optimized
Case study real-world examples of how Thermo Fisher has worked with customers to successfully navigate late-stage media manufacturing

This session includes a Q and A with our presenters immediately following the presentation.